December 06, 2024

Scientists Receives ERC Consolidator Grant – Funding for the Central Institute of Mental Health

Scientists Receives ERC Consolidator Grant – Funding for the Central Institute of Mental Health

An ERC Consolidator Grant will go to PD Dr Gordon Feld, who does research into sleep and memory at the Central Institute of Mental Health in Mannheim and teaches at Ruperto Carola’s Institute of Psychology.

PD Dr Gordon Feld | © Daniel Lukac/ZI

Dr Feld’s project, entitled “Tracking Memory During Sleep: Understanding How Replay of Complex Information Affects Memory and Mental Health” (MemoryTracker), is about how memories are processed during sleep and their potential capacity for treating mental disorders. His research focuses on discovering how current research findings can be transferred – inter alia with the aid of modern neuroscientific methods – into practical psychotherapeutic options. The European Research Council has allocated approximately two million euros to fund the studies over five years. Since 2019, Gordon Feld has headed the Emmy Noether Group “Psychology and Neurobiology of Sleep and Memory”, which is located in the Department Clinical Psychology at the Central Institute of Mental Health. The researcher also teaches at Heidelberg University’s Institute of Psychology.

The European Research Council awards the ERC Consolidator Grant to outstanding researchers with the aim of consolidating their academic independence. The central criterion for funding is scientific excellence.

Our latest News

discover more
Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Effective June 1, 2026, the Supervisory Board has appointed Hanns-Peter Knaebel, Chairman of the Executive Board, to serve as Chief Medical Officer. This move will ensure that the dynamic phase of medical strategy development and transformation within the group is overseen and managed centrally by the full Executive Board. Full Text in German below. Professor […]

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

HEILBRONN, Germany, May 14, 2026 – ProtaGene today announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to provide biopharmaceutical customers with an end-to-end testing solution across the entire biopharmaceutical product lifecycle, from early-stage development through GMP release testing. ProtaGene’s expertise in advanced protein […]

Universität Heidelberg Successful with Application for Collaborative Research Centre

Universität Heidelberg Successful with Application for Collaborative Research Centre

DFG funds extended CRC with approximately 17.4 million euros Heidelberg University has been successful in the latest approval round of the German Research Foundation (DFG) with a grant application for a major research consortium: The Collaborative Research Centre “Molecular Circuits of Heart Disease” (CRC 1550), based at the Medical Faculty Heidelberg, is entering a second […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp